CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 2,699 enrolled
Drug / intervention
Navigator Guidancebehavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03875339
NCT03875339N/ACompleted

Communities Helping the Hearing of Infants by Reaching Parents: The CHHIRP Navigator Trial

Matthew Bush, MD·interventional·Posted Mar 14, 2019·Updated Feb 14, 2025

In Brief

A clinical study evaluating Navigator Guidance for Congenital Hearing Loss. Completed, enrolled 2,699 participants across 2 sites.

Detailed Summary

Hearing loss is the most common sensory congenital disorder and this condition is diagnosable and treatable. Children that are born with hearing loss have to undergo several hearing tests to diagnose the condition and many families are delayed in receiving this testing or never obtain the needed testing. This research employs a new method for helping children with hearing loss receive timely care by using a patient navigator, who is someone who teaches and provides emotional/social support for the families of these children. The hypothesis of this study is that a patient navigator will hasten the timing of pediatric audiological testing, improve compliance with scheduled appointments, and expand parental knowledge of pediatric hearing loss.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States

Timeline

N/ACompletedFinished
20192020202120222023202420252026
First PostedMar 14, 2019
Enrollment StartJan 13, 2021
Primary CompletionSep 8, 2023
TodayJul 2, 2026
Enrollment to primary: 2.7 yearsPosted 7.3 years ago

Interventions

Navigator Guidancebehavioral

Use of a dedicated Navigator to determine if follow-up and compliance rates can be improved for those infants initially demonstrating an abnormal hearing result.